SolveBio has developed an advanced precision medicine technology platform — called Genomic Intelligence Platform — that enables biopharma customers to lower trial risk, create more effective therapeutics, and compress the time scale of clinical development. The company's technology can connect genomic data to outcomes from a rapidly compounding complex landscape of vendors, studies, and patients.
Select investors Andreessen Horowitz, SV Angel, Red Swan Ventures, Great Oaks Venture Capital, Faridan, Max Levchin
Last update: June 10, 2018
Disclaimer: We can not guarantee that the information on this page is 100% correct. more